로딩 중…
지수 로딩 중…
Nurix Therapeutics, Inc.
NRIX· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$17.55+2.51%
2026-06-18
Price Chart
Nurix Therapeutics, Inc.+51.03%
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $1.81B |
| Revenue | $72M |
| Net Income | $-295M |
| Total Assets | $636M |
| Net Assets | $481M |
| Value | |
| P/B | 3.77x |
| P/S | 25.28x |
| FCF Yield | -14.98% |
| Profitability | |
| ROE | -61.40% |
| ROA | -46.42% |
| Op. Margin | -439.26% |
| Revenue Growth | -66.12% |
| Financial Health | |
| Debt Ratio | 32.28% |
| Total Debt | $59M |
| FCF | $-272M |
| Cash | $71M |
| Current Ratio | 6.01x |
| Performance | |
| 1Y Return | 51.03% |
| 1M Return | 15.16% |
| From 52W High | -22.00% |
| 1Y MDD | -37.48% |
| Trading | |
| Volume | 3,229,005 shares |
| Trading Value | $56M |
| Per Share | |
| EPS | $-2.78 |
| BPS | $5.67 |